Antitumor Efficacy of Hypothemycin, A New Ras-signaling Inhibitor
スポンサーリンク
概要
- 論文の詳細を見る
- 1999-10-31
著者
-
YOSHIOKA Takayuki
Shionogi Research Laboratories, Shionogi & Co., Ltd.
-
Sugita Kenji
Shionogi Research Laboratories Shionogi & Co. Ltd.
-
Sugita Kenji
Shionogi Research Laboratories Shionogi & Co. Ltd
-
TANAKA Hidekazu
Shionogi Research Laboratories, Shionogi & Co., Ltd.
-
NISHIDA Kazuyo
Shionogi Research Laboratories, Shionogi & Co., Ltd.
-
Nishida Kazuyo
Shionogi Research Laboratories Shionogi & Co. Ltd.
-
Yoshioka Takayuki
Shionogi Research Laboratories Shionogi & Co. Ltd.
-
Tanaka Hidekazu
Shionogi Research Laboratories Shionogi & Co. Ltd.
関連論文
- Anti-tumor efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor
- Preclinical in vivo Antitumor Efficacy of Nedaplatin with Gemcitabine against Human Lung Cancer
- Improved in vivo Antitumor Efficacy and Reduced Systemic Toxicity of Carboxymethylpullulan-peptide-doxorubicin Conjugates
- Combination Chemotherapy with Nedaplatin and Cyclophosphamide in Human Ovarian Cancer Model
- Antitumor Efficacy of Hypothemycin, A New Ras-signaling Inhibitor